Results for Coagulation Factor VIII

From Mentors to Making it Your Own: Inspiration From Women in STEM

Published on

Mar 8, 2021

Nominated by their Centers of Emphasis, women in STEM share what drives them, their words of wisdom, and why they do what they do.

In the News: 22q, Mentoring Award, Neonatal E. coli, Gene Therapy, Siegel Award

Published on

Nov 20, 2020

in Cornerstone Blog

This week in the news: New awards for our scientists and findings for antibiotic stewardship, gene therapy, and 22q11.2 deletion syndrome.

Samelson-Jones Laboratory

Our lab is interested in the hemostasis system, especially coagulation factor VIII and IX, which are deficient in the bleeding disorders hemophilia A and B. By studying these blood proteins, the lab team aims to improve therapies for children with these diseases including gene therapy.

George Laboratory

Dr. George's clinical and research interests are in the development of novel therapeutics for hemophilia. The George Laboratory studies the molecular basis of coagulation with specific emphasis on the intrinsic tenase enzyme complex.